Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Natural body gas could help treat severe skin and wound infections (opens in a new tab)

news-medical.net · 2026-11-03

Short answerEvidenceSource

Short answer

Not supported

Not supported.

2 claims go further than the study. 2 other points were not covered by the paper.

  • 2 overstated
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Not supported

Two of four claims overstate the study. Two claims the study doesn't address.

  • 2 overstated
  • 2 not covered
Open claim evidence
3

The source study

PEGylated S-Nitrosothiol Organosilica Nanoparticles for pH-Responsive Nitric Oxide Release and Antimicrobial Protection in a Galleria mellonella Infection Model

· 2026
Open source record (opens in a new tab)
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4OverstatedA gas naturally produced by our own bodies could one day help treat skin and wound infections, potentially offering a new approach alongside conventional antibiotics.View evidenceHide evidence

Why this verdict

The abstract-level profile supports nitric-oxide-releasing nanoparticles with in vitro antimicrobial activity and a qualitative beneficial effect in an invertebrate Galleria infection model. It does not establish treatment of human skin or wound infections, use alongside conventional antibiotics, or clinical utility. Because this is a headline claim, its translational wording outruns the paper evidence despite being hedged as 'could one day.'

1

Study evidence

NP-SH-PEG-SNO produced NO-derived nitrite detectable by the Griess assay, and the amount of nitrite detected varied with pH, indicating pH-dependent NO release under the reported in vitro conditions.

“NO release from S-nitrosated nanoparticles was indirectly assessed using the Griess assay, which detected NO-derived nitrite in a pH-dependent manner.”
2

Study evidence

NP-SH-PEG-SNO (S-nitrosated, PEGylated organosilica nanoparticles) significantly inhibited bacterial proliferation in MIC and time-kill assays reported in the abstract.

“Antimicrobial activity was evaluated against Staphylococcus aureus and Escherichia coli using MIC and time-kill assays.”
Claim 2 of 4OverstatedThe article says the findings could give doctors another treatment option for infected wounds that antibiotics struggle to clear, but that more studies are needed before the particles could become a treatment for people.View evidenceHide evidence

Why this verdict

The paper profile supports early preclinical antimicrobial activity in lab assays and an invertebrate infection model, and the story's caveat that more studies are needed before human treatment is appropriate. But the claim that the findings could give doctors another option for infected wounds that antibiotics struggle to clear is a clinical extrapolation not supported by the abstract-level paper profile, which does not study wounds, antibiotic-refractory infections, doctors' treatment options, vertebrates, or humans.

1

Study evidence

NP-SH-PEG-SNO (S-nitrosated, PEGylated organosilica nanoparticles) significantly inhibited bacterial proliferation in MIC and time-kill assays reported in the abstract.

“Antimicrobial activity was evaluated against Staphylococcus aureus and Escherichia coli using MIC and time-kill assays.”
2

Study evidence

NP-SH-PEG-SNO showed beneficial effects against S. aureus infection in the Galleria mellonella model as reported in the abstract.

“Moreover, in an in vivo Galleria mellonella infection model, NP-SH-PEG-SNO showed beneficial effects against S. aureus infection, whereas no pronounced effect was observed against E. coli.”
Claim 3 of 4Not coveredA new study led by scientists at the University of Reading found that tiny particles releasing nitric oxide helped nine in ten infected wax moth larvae survive bacterial infections, compared with around six in ten that were not treated.View evidenceHide evidence

As statednine in ten vs around six in ten

Why this verdict

The abstract reports only that NP-SH-PEG-SNO had beneficial effects against S. aureus infection in Galleria mellonella and no pronounced effect against E. coli. It does not provide survival endpoints, sample sizes, or the claimed magnitude of nine in ten versus around six in ten. The causal framing is plausible for an experimental animal model, but the stated survival numbers and broad 'bacterial infections' wording cannot be verified from the abstract-level profile.

1

Study evidence

NP-SH-PEG-SNO showed beneficial effects against S. aureus infection in the Galleria mellonella model as reported in the abstract.

“Moreover, in an in vivo Galleria mellonella infection model, NP-SH-PEG-SNO showed beneficial effects against S. aureus infection, whereas no pronounced effect was observed against E. coli.”
Claim 4 of 4Not coveredIn separate flask tests, the particles left between 10,000 and 100,000 times fewer bacteria after a day than flasks with no treatment.View evidenceHide evidence

As stated10,000 to 100,000 times fewer bacteria

Why this verdict

The abstract supports in vitro antimicrobial testing by MIC and time-kill assays and says NP-SH-PEG-SNO significantly inhibited bacterial proliferation. However, it provides no bacterial-count values, time-kill curves, 24-hour data, or 10,000- to 100,000-fold magnitude. The direction of effect is supported, but the specific quantitative claim is not verifiable at abstract depth.

1

Study evidence

NP-SH-PEG-SNO (S-nitrosated, PEGylated organosilica nanoparticles) significantly inhibited bacterial proliferation in MIC and time-kill assays reported in the abstract.

“Antimicrobial activity was evaluated against Staphylococcus aureus and Escherichia coli using MIC and time-kill assays.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The study synthesized and characterized thiol-functionalized, PEGylated, S-nitrosated organosilica nanoparticles as the NO-releasing platform, including physicochemical characterization and reported PEGylation-related colloidal stability.

    The story reflects the broad idea of 'tiny particles releasing nitric oxide' but does not cover the material-science contribution: formulation sequence, characterization methods, or PEGylation/stability findings.

    From nanoparticle synthesis and physicochemical characterization

  • In the Galleria mellonella infection model, the abstract reports a beneficial effect against S. aureus but no pronounced effect against E. coli.

    The story reflects use of infected wax moth larvae, but it does not reflect the pathogen-specific limitation that the in vivo benefit was reported for S. aureus whereas no pronounced effect was observed for E. coli. That omission matters because the story frames the larval result more generally as survival from bacterial infections.

    From In vivo Galleria mellonella infection model

2 things the story did carry across
  • In vitro antimicrobial activity was evaluated against Staphylococcus aureus and Escherichia coli using MIC and time-kill assays; NP-SH-PEG-SNO inhibited proliferation while non-S-nitrosated controls showed no antibacterial activity.
  • The work is preclinical and limited to in vitro assays and invertebrate models, not mice, rats, humans, wounds, or clinical treatment settings.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

5

Evidence read

study summary

Lead result

in vivo animal

1Lead resultin vivo animalEvaluate therapeutic/protective efficacy of NP-SH-PEG-SNO in an in vivo Galleria mellonella infection model with S. aureus and E. coli.In vivo Galleria mellonella infection modelExpand

In plain English

Using a Galleria mellonella infection model, the S‑nitrosated PEGylated organosilica nanoparticles (NP-SH-PEG-SNO) produced a reported beneficial effect against Staphylococcus aureus infection, whereas no pronounced effect was observed against Escherichia coli. The abstract does not provide numerical effect sizes, endpoints, or statistical details.

Key findings

  • NP-SH-PEG-SNO showed beneficial effects against S. aureus infection in the Galleria mellonella model as reported in the abstract.
  • NP-SH-PEG-SNO showed no pronounced effect against E. coli infection in the Galleria mellonella model as reported in the abstract.
“Moreover, in an in vivo Galleria mellonella infection model, NP-SH-PEG-SNO showed beneficial effects against S. aureus infection, whereas no pronounced effect was observed against E. coli.”
What this piece can’t prove
  • The terms 'beneficial effects' and 'no pronounced effect' are qualitative and ambiguous without defined endpoints or quantitative metrics.

2 further details could not be confirmed from the summary.

2in vitroSynthesize thiol-functionalized organosilica nanoparticles, PEGylate and S-nitrosate them (NP-SH, NP-SH-PEG, NP-SH-PEG-SNO), and establish their physicochemical properties and colloidal stability as a platform for downstream biological testing.nanoparticle synthesis and physicochemical characterizationExpand

In plain English

Thiol-functionalized organosilica nanoparticles were synthesized, then surface-PEGylated and S‑nitrosated to produce a panel of formulations (NP-SH, NP-SH-PEG, NP-SH-PEG-SNO). The formulations were characterized using TEM, AFM, DLS, ζ‑potential, Ellman’s assay, FTIR and Raman spectroscopy. PEGylation is reported to markedly improve colloidal stability and reduce aggregation under physiological conditions; S‑nitrosated particles showed pH-dependent NO release detected indirectly by the Griess assay.

Key findings

  • A set of organosilica nanoparticle formulations (NP-SH, NP-SH-PEG, NP-SH-PEG-SNO) was synthesized and characterized using TEM, AFM, DLS, ζ‑potential, Ellman’s assay, FTIR and Raman spectroscopy.
  • Surface PEGylation (NP-SH-PEG) is reported to markedly improve colloidal stability and reduce aggregation under physiological conditions, relative to non-PEGylated thiolated particles.
“Thiol-functionalized organosilica nanoparticles were synthesized, followed by their surface PEGylation and subsequent S-nitrosation to prepare nitric oxide-releasing nanoparticles.”
What this piece can’t prove
  • Griess assay provides an indirect measure of NO via nitrite detection; the abstract does not describe orthogonal or direct NO quantification methods.

2 further details could not be confirmed from the summary.

3in vitroDemonstrate pH-responsive nitric oxide (NO) release from S-nitrosated nanoparticles using an indirect nitrite readout.Griess assay (in vitro nitrite proxy across buffered pH)Expand

In plain English

Using an in vitro Griess assay (nitrite quantification) on S‑nitrosated PEGylated organosilica nanoparticles (NP-SH-PEG-SNO), the study reports pH-dependent detection of NO-derived nitrite consistent with pH-responsive NO release.

Key findings

  • NP-SH-PEG-SNO produced NO-derived nitrite detectable by the Griess assay, and the amount of nitrite detected varied with pH, indicating pH-dependent NO release under the reported in vitro conditions.
“NO release from S-nitrosated nanoparticles was indirectly assessed using the Griess assay, which detected NO-derived nitrite in a pH-dependent manner.”
What this piece can’t prove
  • Indirect measurement (nitrite) used rather than a direct NO detection method in the reported assay.

2 further details could not be confirmed from the summary.

4in vivo animalEstablish biocompatibility/toxicological profile of the nanoparticle formulations in invertebrate models (planaria and Galleria mellonella larvae).in vivo invertebrate toxicityExpand

In plain English

The paper reports in vivo toxicological/biocompatibility testing of three organosilica nanoparticle formulations (NP-SH, NP-SH-PEG, NP-SH-PEG-SNO) in two invertebrate models (Schmidtea mediterranea planaria and Galleria mellonella larvae). At abstract-level reporting, these assessments are summarized as demonstrating biocompatibility for all investigated formulations.

Key findings

  • In abstract-level reporting, toxicological assessment in Schmidtea mediterranea planaria and Galleria mellonella larvae demonstrated biocompatibility of NP-SH, NP-SH-PEG, and NP-SH-PEG-SNO.
“Toxicological assessment was performed using Schmidtea mediterranea planaria and Galleria mellonella larvae models, demonstrating the biocompatibility of all investigated nanoparticle formulations.”
What this piece can’t prove
  • Use of invertebrate models limits direct generalizability to vertebrate safety or clinical contexts.

2 further details could not be confirmed from the summary.

5in vitroDemonstrate antimicrobial activity of NP-SH-PEG-SNO versus controls against S. aureus and E. coli in vitro.In vitro MIC and time-kill antimicrobial assaysExpand

In plain English

Abstract reports in vitro antimicrobial testing (MIC and time-kill assays) of three nanoparticle formulations (NP-SH, NP-SH-PEG, NP-SH-PEG-SNO) against Staphylococcus aureus and Escherichia coli. NP-SH-PEG-SNO is reported to significantly inhibit bacterial proliferation in these assays, whereas NP-SH and NP-SH-PEG showed no antibacterial activity. The abstract does not provide MIC values, time-kill curves, concentrations, or statistical detail.

Key findings

  • NP-SH-PEG-SNO (S-nitrosated, PEGylated organosilica nanoparticles) significantly inhibited bacterial proliferation in MIC and time-kill assays reported in the abstract.
  • NP-SH and NP-SH-PEG (thiolated and PEGylated but non-S-nitrosated nanoparticles) showed no antibacterial activity in the reported MIC and time-kill assays.
“Antimicrobial activity was evaluated against Staphylococcus aureus and Escherichia coli using MIC and time-kill assays.”
What this piece can’t prove
  • Summary derived solely from the paper abstract; full methods/results sections are not available here.
  • Strain identifiers, culture conditions, inoculum sizes, and replicate numbers are not provided.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

PEGylated S-Nitrosothiol Organosilica Nanoparticles for pH-Responsive Nitric Oxide Release and Antimicrobial Protection in a Galleria mellonella Infection Model

2026

Source record (opens in a new tab)

Why this one

Confident

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref · 15 candidate papers

Selected

PEGylated S-Nitrosothiol Organosilica Nanoparticles for pH-Responsive Nitric Oxide Release and Antimicrobial Protection in a Galleria mellonella Infection Model

2026 · Crossref

Source (opens in a new tab)
Candidate

Using A Galleria Mellonella to Investigate the Pathogenicity of Brachybacterium epidermidis Isolated from Conjunctivitis Newborn in Mosul City, Iraq

Rafidain Journal of Science · 2026 · Crossref

Source (opens in a new tab)

And 9 more candidates considered.